naltrexone and bupropion SR

DRUG2 trials

Sponsors

Orexigen Therapeutics, Inc, National Institute on Drug Abuse (NIDA)

Conditions

Methamphetamine DependenceObesity

Phase 1

Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study

CompletedNCT01359930

National Institute on Drug Abuse (NIDA)Methamphetamine Dependence

Start: 2011-08-31End: 2012-06-30Target: 16Updated: 2017-01-12

Phase 2

Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity

CompletedNCT00364871

Orexigen Therapeutics, IncObesity

Start: 2005-04-30End: 2007-03-31Updated: 2008-04-22